- Q1 2024 Assertio Holdings Inc Earnings Call TranscriptMay 06, 2024$1.22 (+18.45%)Earnings
- Q4 2023 Assertio Holdings Inc Earnings Call TranscriptMar 11, 2024$0.9347 (+2.52%)Earnings
- Q3 2023 Assertio Holdings Inc Earnings Call TranscriptNov 08, 2023$2.13 (-4.05%)Earnings
- Q2 2023 Assertio Holdings Inc Earnings Call TranscriptAug 03, 2023$5.35 (-1.11%)Earnings
- Q1 2023 Assertio Holdings Inc Earnings Call TranscriptMay 09, 2023$6.98 (+11.50%)Earnings
- Assertio Holdings Inc Acquisition of Spectrum Pharmaceuticals Inc - M&A Call TranscriptApr 25, 2023
- Q4 2022 Assertio Holdings Inc Earnings Call TranscriptMar 08, 2023$5.96 (-3.40%)Earnings
- Assertio Holdings Inc at Issuer Direct Winter Wonderland Best Ideas Investor Conference (Virtual) TranscriptFeb 22, 2023
- Q3 2022 Assertio Holdings Inc Earnings Call TranscriptNov 08, 2022$2.62 (-2.24%)Earnings
- Q2 2022 Assertio Holdings Inc Earnings Call TranscriptAug 08, 2022$3.65 (-8.52%)Earnings
- Q1 2022 Assertio Holdings Inc Earnings Call TranscriptMay 09, 2022$1.88 (-9.62%)Earnings
- Assertio Holdings Inc Annual Shareholders Meeting TranscriptMay 04, 2022
- Q4 2021 Assertio Holdings Inc Earnings Call TranscriptMar 09, 2022$2.6 (+19.27%)Earnings
- Assertio Holdings Inc at Issuer Direct Winter Wonderland Best Ideas Investor Conference (Virtual) TranscriptFeb 08, 2022
- Assertio Holdings Inc at H C Wainwright Bioconnect Conference (Virtual) TranscriptJan 10, 2022
- Q3 2021 Assertio Holdings Inc Earnings Call TranscriptNov 04, 2021$1.11 (-2.63%)Earnings
- Q2 2021 Assertio Holdings Inc Earnings Call TranscriptAug 05, 2021$1.33 (+3.10%)Earnings
- Assertio Holdings Inc Annual Shareholders Meeting TranscriptMay 11, 2021
- Q1 2021 Assertio Holdings Inc Earnings Call TranscriptMay 06, 2021$1.99 (-2.22%)Earnings
- Q4 2020 Assertio Holdings Inc Earnings Call TranscriptMar 11, 2021$3.81 (+1.38%)Earnings
Assertio Holdings Inc at Issuer Direct Winter Wonderland Best Ideas Investor Conference (Virtual) Transcript
Good day, and welcome to the Second Annual Winter Wonderland Best Ideas Conference. The next presenting company is Assertio Holdings, Inc. (Operator Instructions)
I'd now like to turn the floor over to today's host, Daniel Peisert, President and CEO of Assertio Holdings, Inc. Sir, the floor is yours.
Thank you, Matthew, and we're honored to be presenting here today at the Winter Wonderland conference. Let me forward the slides here.
So at a high level, Assertio today is a commercial stage pharmaceutical company with 4 core products that serve as the foundation for our business. Their prescription products in large markets covering non-opioid pain, arthritis and inflammation and migraine. At the time we announced the Otrexup acquisition in December, we also increased our outlook for the full year of 2021 for both revenue and EBITDA. We now expect to exceed $108 million in revenue and exceed $48 million in adjusted EBITDA for 2021. This outlook is well above our initial
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)